来自MSN11 个月
Acorda loses Nasdaq listing to cap biotech’s end
Inbrija (levodopa inhalation powder) and Ampyra (dalfampridine) — also marketed as Fampyra (fampridine) outside of the US — were the company’s lead assets. Inbrija is used to treat patients ...
pharmaphorum3 天
Acorda filed for bankruptcy, and Merz is eyeing its assets
It is possible that other interested parties could come forward. On the table are Acorda’s multiple sclerosis therapy Ampyra/Fampyra (dalfampridine) and Inbrija (levodopa inhalation powder ...